• Skip to primary navigation
  • Skip to main content
  • Skip to footer

Bionor Holding AS

  • About us
  • Functional HIV cure
  • Products
  • Investors
  • News
  • Functional HIV cure
  • Vacc-4x vaccine
  • Vacc-C5 vaccine
  • Platform technology

News

News by the year

Poster presentation at NIH “Strategies for an HIV Cure” meeting in Bethesda, Maryland US

Posted in Scientific 14.11.2016

Bionor Pharma ASA has been selected to present a poster entitled “Approaching HIV Functional Cure Applying Vacc-4x, a peptide-based HIV Therapeutic Vaccine: Clinical Development Methodological Considerations” at the National Institute […]


Poster presentation at the 18th Institute of Human Virology Annual Conference

Posted in Scientific 21.09.2016

Preliminary data from a Bionor research project supported by the Research Council of Norway GLOBVAC program will be presented as a poster today at the 18th Annual International Meeting of […]


Bionor provides an update on scientific collaborations

Posted in Scientific 13.06.2016

(Oslo, Norway, 13 June 2016) Bionor Pharma ASA (Bionor) (OSE:BIONOR), today provides an update on scientific collaborations in relation to the company’s HIV immunotherapy pipeline. On 31 May 2016, the […]


  • « Go to Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Go to page 6
  • Go to page 7
  • Interim pages omitted …
  • Go to page 22
  • Go to Next Page »

Which year do you want to read news?

  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010

    Footer

    • About us
    • Functional HIV cure
    • Products
    • Investors
    • News

    Bionor Holding AS
    Karenslysts Allé 6 – P.O. Box 4115 – NO-0217 Oslo – Norway
    [email protected]